Subcutaneous implantable cardioverter defibrillator for dialysis patients: A strategy to reduce central vein stenoses and infections

Rajiv K. Dhamija, Henry Tan, Edward Philbin, Roy O. Mathew, Mandeep S. Sidhu, Jeffrey Wang, Basil Saour, Syed S. Haqqie, Gerald Beathard, Alexander S. Yevzlin, Loay Salman, William E. Boden, Gary Siskin, Arif Asif

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Central venous stenosis is a common complication of the transvenous leads associated with an implantable cardioverter defibrillator (ICD). Although epicardial leads have been reported to bypass this complication, their placement is much more invasive than the subcutaneous ICDs (SICDs) and requires the services of a cardiothoracic surgeon. Recent data have demonstrated successful defibrillation using an SICD. In this report, we present 4 long-term hemodialysis patients treated successfully with an SICD. 3 patients received the device for primary prevention of sudden cardiac death (cardiomyopathy with low ejection fraction). The patient in the fourth case had a prolonged QT interval and received the device for secondary prevention. 3 patients had an arteriovenous fistula, whereas 1 patient was dialyzing with a tunneled dialysis catheter. Insertion of an SICD is a minimally invasive procedure. By virtue of leaving the venous system untouched, this approach might offer the advantage of reduced risk of central venous stenosis and infection over an endocardial ICD with transvenous leads. SICD is not experimental; it has been approved by the US Food and Drug Administration and is currently being used in the United States and Europe.

Original languageEnglish (US)
Pages (from-to)154-158
Number of pages5
JournalAmerican Journal of Kidney Diseases
Volume66
Issue number1
DOIs
StatePublished - Jul 1 2015

Fingerprint

Implantable Defibrillators
Dialysis
Veins
Pathologic Constriction
Infection
Equipment and Supplies
Sudden Cardiac Death
Arteriovenous Fistula
United States Food and Drug Administration
Primary Prevention
Secondary Prevention
Cardiomyopathies
Renal Dialysis
Catheters

Keywords

  • arteriovenous fistula (AVF)
  • cardiac leads
  • central venous stenosis
  • end-stage renal disease (ESRD)
  • hemodialysis
  • infection
  • Subcutaneous implantable cardioverter defibrillator (SICD)
  • tunneled dialysis catheter
  • venous occlusion

ASJC Scopus subject areas

  • Nephrology

Cite this

Subcutaneous implantable cardioverter defibrillator for dialysis patients : A strategy to reduce central vein stenoses and infections. / Dhamija, Rajiv K.; Tan, Henry; Philbin, Edward; Mathew, Roy O.; Sidhu, Mandeep S.; Wang, Jeffrey; Saour, Basil; Haqqie, Syed S.; Beathard, Gerald; Yevzlin, Alexander S.; Salman, Loay; Boden, William E.; Siskin, Gary; Asif, Arif.

In: American Journal of Kidney Diseases, Vol. 66, No. 1, 01.07.2015, p. 154-158.

Research output: Contribution to journalArticle

Dhamija, RK, Tan, H, Philbin, E, Mathew, RO, Sidhu, MS, Wang, J, Saour, B, Haqqie, SS, Beathard, G, Yevzlin, AS, Salman, L, Boden, WE, Siskin, G & Asif, A 2015, 'Subcutaneous implantable cardioverter defibrillator for dialysis patients: A strategy to reduce central vein stenoses and infections', American Journal of Kidney Diseases, vol. 66, no. 1, pp. 154-158. https://doi.org/10.1053/j.ajkd.2015.01.028
Dhamija, Rajiv K. ; Tan, Henry ; Philbin, Edward ; Mathew, Roy O. ; Sidhu, Mandeep S. ; Wang, Jeffrey ; Saour, Basil ; Haqqie, Syed S. ; Beathard, Gerald ; Yevzlin, Alexander S. ; Salman, Loay ; Boden, William E. ; Siskin, Gary ; Asif, Arif. / Subcutaneous implantable cardioverter defibrillator for dialysis patients : A strategy to reduce central vein stenoses and infections. In: American Journal of Kidney Diseases. 2015 ; Vol. 66, No. 1. pp. 154-158.
@article{8a4d43d6ea104d64919fb2d5a8447147,
title = "Subcutaneous implantable cardioverter defibrillator for dialysis patients: A strategy to reduce central vein stenoses and infections",
abstract = "Central venous stenosis is a common complication of the transvenous leads associated with an implantable cardioverter defibrillator (ICD). Although epicardial leads have been reported to bypass this complication, their placement is much more invasive than the subcutaneous ICDs (SICDs) and requires the services of a cardiothoracic surgeon. Recent data have demonstrated successful defibrillation using an SICD. In this report, we present 4 long-term hemodialysis patients treated successfully with an SICD. 3 patients received the device for primary prevention of sudden cardiac death (cardiomyopathy with low ejection fraction). The patient in the fourth case had a prolonged QT interval and received the device for secondary prevention. 3 patients had an arteriovenous fistula, whereas 1 patient was dialyzing with a tunneled dialysis catheter. Insertion of an SICD is a minimally invasive procedure. By virtue of leaving the venous system untouched, this approach might offer the advantage of reduced risk of central venous stenosis and infection over an endocardial ICD with transvenous leads. SICD is not experimental; it has been approved by the US Food and Drug Administration and is currently being used in the United States and Europe.",
keywords = "arteriovenous fistula (AVF), cardiac leads, central venous stenosis, end-stage renal disease (ESRD), hemodialysis, infection, Subcutaneous implantable cardioverter defibrillator (SICD), tunneled dialysis catheter, venous occlusion",
author = "Dhamija, {Rajiv K.} and Henry Tan and Edward Philbin and Mathew, {Roy O.} and Sidhu, {Mandeep S.} and Jeffrey Wang and Basil Saour and Haqqie, {Syed S.} and Gerald Beathard and Yevzlin, {Alexander S.} and Loay Salman and Boden, {William E.} and Gary Siskin and Arif Asif",
year = "2015",
month = "7",
day = "1",
doi = "10.1053/j.ajkd.2015.01.028",
language = "English (US)",
volume = "66",
pages = "154--158",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Subcutaneous implantable cardioverter defibrillator for dialysis patients

T2 - A strategy to reduce central vein stenoses and infections

AU - Dhamija, Rajiv K.

AU - Tan, Henry

AU - Philbin, Edward

AU - Mathew, Roy O.

AU - Sidhu, Mandeep S.

AU - Wang, Jeffrey

AU - Saour, Basil

AU - Haqqie, Syed S.

AU - Beathard, Gerald

AU - Yevzlin, Alexander S.

AU - Salman, Loay

AU - Boden, William E.

AU - Siskin, Gary

AU - Asif, Arif

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Central venous stenosis is a common complication of the transvenous leads associated with an implantable cardioverter defibrillator (ICD). Although epicardial leads have been reported to bypass this complication, their placement is much more invasive than the subcutaneous ICDs (SICDs) and requires the services of a cardiothoracic surgeon. Recent data have demonstrated successful defibrillation using an SICD. In this report, we present 4 long-term hemodialysis patients treated successfully with an SICD. 3 patients received the device for primary prevention of sudden cardiac death (cardiomyopathy with low ejection fraction). The patient in the fourth case had a prolonged QT interval and received the device for secondary prevention. 3 patients had an arteriovenous fistula, whereas 1 patient was dialyzing with a tunneled dialysis catheter. Insertion of an SICD is a minimally invasive procedure. By virtue of leaving the venous system untouched, this approach might offer the advantage of reduced risk of central venous stenosis and infection over an endocardial ICD with transvenous leads. SICD is not experimental; it has been approved by the US Food and Drug Administration and is currently being used in the United States and Europe.

AB - Central venous stenosis is a common complication of the transvenous leads associated with an implantable cardioverter defibrillator (ICD). Although epicardial leads have been reported to bypass this complication, their placement is much more invasive than the subcutaneous ICDs (SICDs) and requires the services of a cardiothoracic surgeon. Recent data have demonstrated successful defibrillation using an SICD. In this report, we present 4 long-term hemodialysis patients treated successfully with an SICD. 3 patients received the device for primary prevention of sudden cardiac death (cardiomyopathy with low ejection fraction). The patient in the fourth case had a prolonged QT interval and received the device for secondary prevention. 3 patients had an arteriovenous fistula, whereas 1 patient was dialyzing with a tunneled dialysis catheter. Insertion of an SICD is a minimally invasive procedure. By virtue of leaving the venous system untouched, this approach might offer the advantage of reduced risk of central venous stenosis and infection over an endocardial ICD with transvenous leads. SICD is not experimental; it has been approved by the US Food and Drug Administration and is currently being used in the United States and Europe.

KW - arteriovenous fistula (AVF)

KW - cardiac leads

KW - central venous stenosis

KW - end-stage renal disease (ESRD)

KW - hemodialysis

KW - infection

KW - Subcutaneous implantable cardioverter defibrillator (SICD)

KW - tunneled dialysis catheter

KW - venous occlusion

UR - http://www.scopus.com/inward/record.url?scp=84937513904&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937513904&partnerID=8YFLogxK

U2 - 10.1053/j.ajkd.2015.01.028

DO - 10.1053/j.ajkd.2015.01.028

M3 - Article

C2 - 25911316

AN - SCOPUS:84937513904

VL - 66

SP - 154

EP - 158

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 1

ER -